SLC25A24 mutation showed the highest HR in breast invasive cancer among all SLC25 genes, and it also showed certain risk effects in mesothelioma, ovarian serous cystadenocarcinoma, and thyroid carcinoma. The gene discussed is SLC25A24; the disease is invasive breast carcinoma.